RA Capital Management, L.P. 13D and 13G filings for Edgewise Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-29 4:30 pm Purchase |
2024-01-19 | 13G | Edgewise Therapeutics, Inc. EWTX |
RA Capital Management, L.P. | 8,909,091 9.600% |
8,909,091 (New Position) |
Filing |
| 2022-08-15 4:59 pm Sale |
2022-08-15 | 13G | Edgewise Therapeutics, Inc. EWTX |
RA Capital Management, L.P. | 0 0.000% |
-2,613,623 (Position Closed) |
Filing |
| 2022-02-14 4:11 pm Purchase |
2021-12-31 | 13G | Edgewise Therapeutics, Inc. EWTX |
RA Capital Management, L.P. | 2,613,623 5.300% |
2,613,623 (New Position) |
Filing |